Faculty

Institution

Unit

Venue

Marta Batus

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMarta Batus is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Marta Batus

Rush University

You can click a keyword to filter the displayed items

oncology thoracic oncology radiation oncology lung cancer cancer care cancer research cancer treatment medicine pharmacology clinical research medicinal research cancer immunotherapy pathology cancer management cancer biology clinical radiation oncology cellular therapy tumor biology respiratory medicine surgical oncology sarcoma oncogenes cancer genomics immune checkpoint inhibitors molecular cancer bronchial neoplasm clinical mycology disease progression overall survival anti-cancer agents survival analysis cancer cells cancer imaging thoracic surgery pharmacotherapy prognosis hematological malignancies tumor targeting lymphoid neoplasia cancer risk cancer genetics clinical evidence molecular diagnostics vascular biology jama oncology prognostic biomarkers thrombosis oncologic imaging cancer growth biomarker (medicine) soft tissue sarcoma malignant disease prognostic evaluation weight gain tumoral pathology treatment and prevention combined modality treatment tumor suppressors non-small-cell lung cancer future directions clinical dermatology advanced lung disease renal function clinical presentation cancer education metastatic melanoma current strategies optimal management longitudinal neutrophil five-year survival proinflammatory reactants clinical outcome oa01.04 five-year survival es-sclc treated extension study results locoregional failure

Notable Scholarly Works

Notable Federal Grants

Collaborators

Chest Pain and St-Segment Elevation. JACC Case Reports (2024)

cardiovascular diseasecardiologychest painacute myocardial infarctionstructural heart diseasecardiovascular imagingchest injuryemergency medicine

Five-Year Survival in Patients With Extensive-Stage Small Cell Lung Cancer Treated With Atezolizumab in the Phase III Impower133 Study and the Phase III Imbrella a Extension Study. Lung Cancer (2024)

pathologyradiation oncologybronchial neoplasmlung cancerimmune checkpoint inhibitorsmedicinethoracic oncologyfive-year survivalcancer treatmentcancer careoncology

Frequency of Weight and Body Composition Increases in Advanced Non‐Small Cell Lung Cancer Patients During First Line Therapy. Journal of Cachexia Sarcopenia and Muscle (2024)

Philip BonomiHita MoudgalyaSandra L. GomezPalmi ShahSanjib BasuMarta BatusLevi B. MartinkaAhmed AbdelkaderIphigenia TzameliSonia CobainSusie CollinsEdmund J. KeliherDanna M. BreenRoberto A. CalleMary Jo FidlerJeffrey A. Borgia

radiation oncologycancer carefirst line therapybody compositioncell therapylung cancerthoracic oncologycancer treatmenthealth sciencesoncology

Association Between Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Survival in Undifferentiated Pleomorphic Sarcoma (Nlr, Plr, and Overall Survival in Ups). Surgical Oncology (2023)

platelet-lymphocyte ratiopathologyundifferentiated pleomorphic sarcomasarcomahematologyoverall survivalcancer researchmedicineoncology

Oa01.04 Five-Year Survival in Patients With Es-Sclc Treated With Atezolizumab in Impower133: Imbrella a Extension Study Results. Journal of Thoracic Oncology (2023)

pathologyhematological malignanciesoa01.04 five-year survivaljama oncologymedicineclinical researchpharmacotherapyes-sclc treatedcancer treatmentclinical trialsoncologyextension study results

Po-1451 Neutrophil-Lymphocyte Ratio Dynamics Associated With Survival After Sbrt for Stage I-II Lung Cancer. Radiotherapy and Oncology (2023)

pathologyimmunologybronchial neoplasmlung cancerthoracic oncologycancer cellsimmune checkpoint inhibitorsoncology

Rna Sequencing to Characterize Pathways in Egfr-Mutated Non-Small Cell Lung Cancer.. Journal of Clinical Oncology (2023)

oncogenespathologytumor biologybronchial neoplasmcell biologylung cancermolecular diagnosticsthoracic oncologycancer genomicstranscriptome

Clinical and Laboratory Parameters Associated With Rapid Progression in Advanced Nsclc Patients Treated With Second or Third-Line Single Agent Immune Checkpoint Inhibitors (Icis).. Journal of Clinical Oncology (2022)

Megan RandallPhilip D. BonomiSanjib BasuJeffrey Allen BorgiaHita MoudgalyaRevathi KolliparaMarta BatusMary Jo J. Fidler

anti-cancer agentssurgical oncologypharmacologyclinical immunologycancer immunotherapyadvanced nsclc patientsimmunotherapyjama oncologylaboratory parameterscancer treatmentmedical mycologyradiation oncologyrapid progressioncancer careclinical radiation oncologyclinical trialsclinical mycologymedicineclinical transplantationclinical researchoncology

Does Synovial Sarcoma Grade Predict Oncologic Outcomes, and Does a Low‐Grade Variant Exist?. Journal of Surgical Oncology (2022)

Michael FiceAbdullah AlmajnooniCharles GushoReagan ChapmanSubramanya MallikarjunappaMarta BatusSteven GitelisMatthew ColmanIra MillerAlan Blank

surgerysarcomasurgical oncologysynovial sarcomalow-grade variant existoncology

Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-Small Cell Lung Cancer. Cureus (2022)

radiation oncologypoor riskbronchial neoplasmdefinitive chemoradiationlung cancerradiologythoracic oncologypatient populationmultiple pulmonary nodulecancer careoncology

1
2
3
4
5
14
10 / page

Marta Batus

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

News & Events

Rush University

NoneMarta Batus is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Marta Batus

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Chest Pain and St-Segment Elevation. JACC Case Reports (2024)

cardiovascular diseasecardiologychest painacute myocardial infarctionstructural heart diseasecardiovascular imagingchest injuryemergency medicine

pathologyradiation oncologybronchial neoplasmlung cancerimmune checkpoint inhibitorsmedicinethoracic oncologyfive-year survivalcancer treatmentcancer careoncology

Frequency of Weight and Body Composition Increases in Advanced Non‐Small Cell Lung Cancer Patients During First Line Therapy. Journal of Cachexia Sarcopenia and Muscle (2024)

radiation oncologycancer carefirst line therapybody compositioncell therapylung cancerthoracic oncologycancer treatmenthealth sciencesoncology

Association Between Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Survival in Undifferentiated Pleomorphic Sarcoma (Nlr, Plr, and Overall Survival in Ups). Surgical Oncology (2023)

platelet-lymphocyte ratiopathologyundifferentiated pleomorphic sarcomasarcomahematologyoverall survivalcancer researchmedicineoncology

Oa01.04 Five-Year Survival in Patients With Es-Sclc Treated With Atezolizumab in Impower133: Imbrella a Extension Study Results. Journal of Thoracic Oncology (2023)

pathologyhematological malignanciesoa01.04 five-year survivaljama oncologymedicineclinical researchpharmacotherapyes-sclc treatedcancer treatmentclinical trialsoncologyextension study results

Po-1451 Neutrophil-Lymphocyte Ratio Dynamics Associated With Survival After Sbrt for Stage I-II Lung Cancer. Radiotherapy and Oncology (2023)

pathologyimmunologybronchial neoplasmlung cancerthoracic oncologycancer cellsimmune checkpoint inhibitorsoncology

Rna Sequencing to Characterize Pathways in Egfr-Mutated Non-Small Cell Lung Cancer.. Journal of Clinical Oncology (2023)

oncogenespathologytumor biologybronchial neoplasmcell biologylung cancermolecular diagnosticsthoracic oncologycancer genomicstranscriptome

Megan RandallPhilip D. BonomiSanjib BasuJeffrey Allen BorgiaHita MoudgalyaRevathi KolliparaMarta BatusMary Jo J. Fidler

Does Synovial Sarcoma Grade Predict Oncologic Outcomes, and Does a Low‐Grade Variant Exist?. Journal of Surgical Oncology (2022)

Michael FiceAbdullah AlmajnooniCharles GushoReagan ChapmanSubramanya MallikarjunappaMarta BatusSteven GitelisMatthew ColmanIra MillerAlan Blank

surgerysarcomasurgical oncologysynovial sarcomalow-grade variant existoncology

Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-Small Cell Lung Cancer. Cureus (2022)

radiation oncologypoor riskbronchial neoplasmdefinitive chemoradiationlung cancerradiologythoracic oncologypatient populationmultiple pulmonary nodulecancer careoncology

1
2
3
4
5
14
10 / page